Samsara Opportunity Fund, L.P.
10% Owner · Kalaris Therapeutics, Inc.
Every open-market stock purchase Samsara Opportunity Fund, L.P. has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. Insiders sell for many reasons, but they buy with their own money for one — this page tracks where how the prices paid compare to where the stock trades now.
Where the buys stand today
- KLRSKalaris Therapeutics, Inc.
One purchase totalling $5.0M at an average of $10.42 per share. See all insider buying in KLRS →
Avg price paid$10.42Latest price—Market capUnknown
All reported buys
Get alerted the next time Samsara Opportunity Fund, L.P. — or any insider — buys
We watch every Form 4 as it hits SEC EDGAR and alert you when insiders cluster into the same stock.
About this data
Figures are parsed from Samsara Opportunity Fund, L.P.'s Form 4 filings on SEC EDGAR (CIK 2086193) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.
This page is informational and reflects public filing data. It is not investment advice.